🇺🇸 CHONDRON in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Herpes Zoster — 1 report (12.5%)
2. Intestinal Obstruction — 1 report (12.5%)
3. Mucosal Inflammation — 1 report (12.5%)
4. Pancreatic Carcinoma — 1 report (12.5%)
5. Postoperative Adhesion — 1 report (12.5%)
6. Postoperative Ileus — 1 report (12.5%)
7. Small Intestine Carcinoma — 1 report (12.5%)
8. White Blood Cell Count Decreased — 1 report (12.5%)

Source database →

Frequently asked questions

Is CHONDRON approved in United States?

CHONDRON does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for CHONDRON in United States?

Sewon Cellontech Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.